A Candidate For A Zika Virus Vaccine Passes Mouse Trials. What’s Next?
Author: Antonio Gregorio Dias Jr Edited by: Layal Liverpool and Inês Barreiros Originally published on the Science Innovation Union (Blog ). Looking at the burden of Zika virus in the Americas during its most recent outbreak, a vaccine is urgently needed. Above all, it must protect pregnant women and the developing foetus from the teratogenic effects that Zika virus infection can cause. To tackle this issue, scientists all over the world have been working on the development of vaccine candidates. More recently, advances in a live-attenuated vaccine have generated promising results in mice and tests in non-human primates are now well underway. A live-attenuated Zika virus vaccine As the name suggests, a live-attenuated vaccine means the generation and use of a “live” Zika virus particle with a lowered ability to infect and replicate within its host. This might sound strange and scary…, but has this been successful before? Yes! The Yellow Fever virus vaccine is a good example. It ...